Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Caffe Canna is a cannabinoid-infused dietary supplement marketed as a weight-loss coffee. Developed and distributed by the multi-level marketing company NEWYOU, the product is an organic dark roast coffee blend containing a proprietary mix of cannabinoids known as "Canna-Actives" (primarily CBD) alongside several botanical extracts and metabolic enhancers. Key active ingredients include Green Tea Extract, Ginseng, Super Citrimax (Garcinia Cambogia), Green Coffee Bean extract, L-Carnitine, ChromeMate, Phaseolamin, Cassiolamine, and Erythroxylon Coca. It is designed to promote weight loss by suppressing appetite, increasing metabolic rate, and enhancing energy levels. As a dietary supplement, it is not FDA-approved for the treatment of any medical condition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Caffe Canna.